PEPGEN INC. Capital Expenditures
PEPGEN INC. (PEPG) reported Capital Expenditures of $30.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- PEPGEN INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $30.00K, a 30.23% decline year-over-year.
- PEPGEN INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- PEPGEN INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was -$1.00K, a 100.44% decline year-over-year.
- PEPGEN INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $97.00K, a 47.57% decline year-over-year.
- PEPGEN INC. payments to acquire property, plant, and equipment for fiscal 2025 was $264.00K, a 46.88% decline from fiscal 2024.
- PEPGEN INC. payments to acquire property, plant, and equipment for fiscal 2024 was $497.00K, a 80.88% decline from fiscal 2023.
- PEPGEN INC. payments to acquire property, plant, and equipment for fiscal 2023 was $2.60M, a 30.79% decline from fiscal 2022.
- PEPGEN INC. payments to acquire property, plant, and equipment for fiscal 2022 was $3.75M, a 651.00% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $30.00K 10-Q · filed 2026-08-06 | $29.00K derived: sum of 3 quarters · filed 2026-08-06 | $126.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | -$1.00K derived: sum of 2 quarters · filed 2026-05-12 | $96.00K derived: sum of 3 quarters · filed 2026-05-12 | $139.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $96.00K derived: sum of 2 quarters · filed 2026-03-04 | $139.00K derived: sum of 3 quarters · filed 2026-08-06 | $264.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | $97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $140.00K derived: sum of 2 quarters · filed 2026-08-06 | $265.00K 10-Q · filed 2025-11-12 | $493.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $168.00K 10-Q · filed 2026-08-06 | $396.00K derived: sum of 3 quarters · filed 2026-08-06 | $581.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $125.00K 10-Q · filed 2026-05-12 | $353.00K derived: sum of 2 quarters · filed 2026-05-12 | $538.00K derived: sum of 3 quarters · filed 2026-05-12 | $569.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $413.00K derived: sum of 2 quarters · filed 2026-03-04 | $444.00K derived: sum of 3 quarters · filed 2026-03-04 | $497.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $185.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $216.00K derived: sum of 2 quarters · filed 2025-11-12 | $269.00K 10-Q · filed 2025-11-12 | $453.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $84.00K 10-Q · filed 2025-08-07 | $268.00K derived: sum of 3 quarters · filed 2025-08-07 | $493.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $53.00K 10-Q · filed 2025-05-08 | $237.00K derived: sum of 2 quarters · filed 2025-05-08 | $462.00K derived: sum of 3 quarters · filed 2025-05-08 | $1.47M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $184.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $409.00K derived: sum of 2 quarters · filed 2025-02-24 | $1.42M derived: sum of 3 quarters · filed 2025-02-24 | $2.60M 10-K · filed 2025-02-24 |
| 2023-09-30 | $225.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.23M derived: sum of 2 quarters · filed 2024-11-07 | $2.42M 10-Q · filed 2024-11-07 | $3.52M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.19M 10-Q · filed 2024-08-08 | $3.29M derived: sum of 3 quarters · filed 2024-08-08 | $3.72M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.18M 10-Q · filed 2024-05-14 | $2.28M derived: sum of 2 quarters · filed 2024-05-14 | $2.71M derived: sum of 3 quarters · filed 2024-05-14 | $3.32M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.10M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-29 | $1.53M derived: sum of 2 quarters · filed 2024-03-29 | $2.14M derived: sum of 3 quarters · filed 2024-03-29 | $3.75M 10-K/A · filed 2024-03-29 |
| 2022-09-30 | $430.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.04M derived: sum of 2 quarters · filed 2023-11-08 | $2.65M 10-Q · filed 2023-11-08 | $2.81M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $609.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.22M 10-Q · filed 2023-08-08 | $2.38M derived: sum of 3 quarters · filed 2023-08-08 | $2.40M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.61M 10-Q · filed 2023-05-11 | $1.77M derived: sum of 2 quarters · filed 2023-05-11 | $1.79M derived: sum of 3 quarters · filed 2023-05-11 | $1.81M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $180.00K derived: sum of 2 quarters · filed 2023-03-23 | $195.00K derived: sum of 3 quarters · filed 2023-03-23 | $500.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $39.00K derived: sum of 2 quarters · filed 2022-11-10 | $344.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $320.00K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $305.00K 10-Q · filed 2022-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |